317 related articles for article (PubMed ID: 32129445)
1. Advancing biology-based therapeutic approaches for atypical teratoid rhabdoid tumors.
Hoffman LM; Richardson EA; Ho B; Margol A; Reddy A; Lafay-Cousin L; Chi S; Slavc I; Judkins A; Hasselblatt M; Bourdeaut F; Frühwald MC; Vibhakar R; Bouffet E; Huang A
Neuro Oncol; 2020 Jul; 22(7):944-954. PubMed ID: 32129445
[TBL] [Abstract][Full Text] [Related]
2. Cribriform neuroepithelial tumor: molecular characterization of a SMARCB1-deficient non-rhabdoid tumor with favorable long-term outcome.
Johann PD; Hovestadt V; Thomas C; Jeibmann A; Heß K; Bens S; Oyen F; Hawkins C; Pierson CR; Aldape K; Kim SP; Widing E; Sumerauer D; Hauser P; van Landeghem F; Ryzhova M; Korshunov A; Capper D; Jones DTW; Pfister SM; Schneppenheim R; Siebert R; Paulus W; Frühwald MC; Kool M; Hasselblatt M
Brain Pathol; 2017 Jul; 27(4):411-418. PubMed ID: 27380723
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of nuclear export restores nuclear localization and residual tumor suppressor function of truncated SMARCB1/INI1 protein in a molecular subset of atypical teratoid/rhabdoid tumors.
Pathak R; Zin F; Thomas C; Bens S; Gayden T; Karamchandani J; Dudley RW; Nemes K; Johann PD; Oyen F; Kordes U; Jabado N; Siebert R; Paulus W; Kool M; Frühwald MC; Albrecht S; Kalpana GV; Hasselblatt M
Acta Neuropathol; 2021 Aug; 142(2):361-374. PubMed ID: 34003336
[TBL] [Abstract][Full Text] [Related]
4. Atypical teratoid/rhabdoid tumors (ATRTs) with SMARCA4 mutation are molecularly distinct from SMARCB1-deficient cases.
Holdhof D; Johann PD; Spohn M; Bockmayr M; Safaei S; Joshi P; Masliah-Planchon J; Ho B; Andrianteranagna M; Bourdeaut F; Huang A; Kool M; Upadhyaya SA; Bendel AE; Indenbirken D; Foulkes WD; Bush JW; Creytens D; Kordes U; Frühwald MC; Hasselblatt M; Schüller U
Acta Neuropathol; 2021 Feb; 141(2):291-301. PubMed ID: 33331994
[TBL] [Abstract][Full Text] [Related]
5. Sellar Region Atypical Teratoid/Rhabdoid Tumors (ATRT) in Adults Display DNA Methylation Profiles of the ATRT-MYC Subgroup.
Johann PD; Bens S; Oyen F; Wagener R; Giannini C; Perry A; Raisanen JM; Reis GF; Nobusawa S; Arita K; Felsberg J; Reifenberger G; Agaimy A; Buslei R; Capper D; Pfister SM; Schneppenheim R; Siebert R; Frühwald MC; Paulus W; Kool M; Hasselblatt M
Am J Surg Pathol; 2018 Apr; 42(4):506-511. PubMed ID: 29324471
[TBL] [Abstract][Full Text] [Related]
6. Integrated (epi)-Genomic Analyses Identify Subgroup-Specific Therapeutic Targets in CNS Rhabdoid Tumors.
Torchia J; Golbourn B; Feng S; Ho KC; Sin-Chan P; Vasiljevic A; Norman JD; Guilhamon P; Garzia L; Agamez NR; Lu M; Chan TS; Picard D; de Antonellis P; Khuong-Quang DA; Planello AC; Zeller C; Barsyte-Lovejoy D; Lafay-Cousin L; Letourneau L; Bourgey M; Yu M; Gendoo DMA; Dzamba M; Barszczyk M; Medina T; Riemenschneider AN; Morrissy AS; Ra YS; Ramaswamy V; Remke M; Dunham CP; Yip S; Ng HK; Lu JQ; Mehta V; Albrecht S; Pimentel J; Chan JA; Somers GR; Faria CC; Roque L; Fouladi M; Hoffman LM; Moore AS; Wang Y; Choi SA; Hansford JR; Catchpoole D; Birks DK; Foreman NK; Strother D; Klekner A; Bognár L; Garami M; Hauser P; Hortobágyi T; Wilson B; Hukin J; Carret AS; Van Meter TE; Hwang EI; Gajjar A; Chiou SH; Nakamura H; Toledano H; Fried I; Fults D; Wataya T; Fryer C; Eisenstat DD; Scheinemann K; Fleming AJ; Johnston DL; Michaud J; Zelcer S; Hammond R; Afzal S; Ramsay DA; Sirachainan N; Hongeng S; Larbcharoensub N; Grundy RG; Lulla RR; Fangusaro JR; Druker H; Bartels U; Grant R; Malkin D; McGlade CJ; Nicolaides T; Tihan T; Phillips J; Majewski J; Montpetit A; Bourque G; Bader GD; Reddy AT; Gillespie GY; Warmuth-Metz M; Rutkowski S; Tabori U; Lupien M; Brudno M; Schüller U; Pietsch T; Judkins AR; Hawkins CE; Bouffet E; Kim SK; Dirks PB; Taylor MD; Erdreich-Epstein A; Arrowsmith CH; De Carvalho DD; Rutka JT; Jabado N; Huang A
Cancer Cell; 2016 Dec; 30(6):891-908. PubMed ID: 27960086
[TBL] [Abstract][Full Text] [Related]
7. Atypical teratoid/rhabdoid tumoroids reveal subgroup-specific drug vulnerabilities.
Paassen I; Williams J; Ríos Arceo C; Ringnalda F; Mercer KS; Buhl JL; Moreno N; Federico A; Franke NE; Kranendonk M; Upadhyaya SA; Kerl K; van de Wetering M; Clevers H; Kool M; Hoving EW; Roussel MF; Drost J
Oncogene; 2023 May; 42(20):1661-1671. PubMed ID: 37020038
[TBL] [Abstract][Full Text] [Related]
8. Functional relevance of genes predicted to be affected by epigenetic alterations in atypical teratoid/rhabdoid tumors.
Tegeder I; Thiel K; Erkek S; Johann PD; Berlandi J; Thatikonda V; Frühwald MC; Kool M; Jeibmann A; Hasselblatt M
J Neurooncol; 2019 Jan; 141(1):43-55. PubMed ID: 30446899
[TBL] [Abstract][Full Text] [Related]
9. Malignant rhabdoid tumors originating within and outside the central nervous system are clinically and molecularly heterogeneous.
Pinto EM; Hamideh D; Bahrami A; Orr BA; Lin T; Pounds S; Zambetti GP; Pappo AS; Gajjar A; Agnihotri S; Broniscer A
Acta Neuropathol; 2018 Aug; 136(2):315-326. PubMed ID: 29428974
[TBL] [Abstract][Full Text] [Related]
10. Spontaneous Regression of Atypical Teratoid Rhabdoid Tumor Without Therapy in a Patient With Uncommon Regional Inactivation of SMARCB1 ( hSNF5/INI1).
Peterson JEG; Bavle A; Mehta VP; Rauch RA; Whitehead WE; Mohila CA; Su JM; Adesina AM
Pediatr Dev Pathol; 2019; 22(2):161-165. PubMed ID: 30470167
[TBL] [Abstract][Full Text] [Related]
11. Atypical teratoid rhabdoid tumor (ATRT): disease mechanisms and potential drug targets.
Rechberger JS; Nesvick CL; Daniels DJ
Expert Opin Ther Targets; 2022 Mar; 26(3):187-192. PubMed ID: 35142587
[No Abstract] [Full Text] [Related]
12. SMAD dependent signaling plays a detrimental role in a fly model of SMARCB1-deficiency and the biology of atypical teratoid/rhabdoid tumors.
Jeibmann A; Schulz J; Eikmeier K; Johann PD; Thiel K; Tegeder I; Ambrée O; Frühwald MC; Pfister SM; Kool M; Paulus W; Hasselblatt M
J Neurooncol; 2017 Feb; 131(3):477-484. PubMed ID: 28108836
[TBL] [Abstract][Full Text] [Related]
13. Description of a new oncogenic mechanism for atypical teratoid rhabdoid tumors in patients with ring chromosome 22.
Byers HM; Adam MP; LaCroix A; Leary SE; Cole B; Dobyns WB; Mefford HC
Am J Med Genet A; 2017 Jan; 173(1):245-249. PubMed ID: 27734605
[TBL] [Abstract][Full Text] [Related]
14. Atypical teratoid rhabdoid tumor: molecular insights and translation to novel therapeutics.
Nesvick CL; Lafay-Cousin L; Raghunathan A; Bouffet E; Huang AA; Daniels DJ
J Neurooncol; 2020 Oct; 150(1):47-56. PubMed ID: 33021733
[TBL] [Abstract][Full Text] [Related]
15. SMARCB1 loss induces druggable cyclin D1 deficiency via upregulation of MIR17HG in atypical teratoid rhabdoid tumors.
Xue Y; Zhu X; Meehan B; Venneti S; Martinez D; Morin G; Maïga RI; Chen H; Papadakis AI; Johnson RM; O'Sullivan MJ; Erdreich-Epstein A; Gotlieb WH; Park M; Judkins AR; Pelletier J; Foulkes WD; Rak J; Huang S
J Pathol; 2020 Sep; 252(1):77-87. PubMed ID: 32558936
[TBL] [Abstract][Full Text] [Related]
16. Molecular subgrouping of atypical teratoid/rhabdoid tumors-a reinvestigation and current consensus.
Ho B; Johann PD; Grabovska Y; De Dieu Andrianteranagna MJ; Yao F; Frühwald M; Hasselblatt M; Bourdeaut F; Williamson D; Huang A; Kool M
Neuro Oncol; 2020 May; 22(5):613-624. PubMed ID: 31889194
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of MYC attenuates tumor cell self-renewal and promotes senescence in SMARCB1-deficient Group 2 atypical teratoid rhabdoid tumors to suppress tumor growth in vivo.
Alimova I; Pierce A; Danis E; Donson A; Birks DK; Griesinger A; Foreman NK; Santi M; Soucek L; Venkataraman S; Vibhakar R
Int J Cancer; 2019 Apr; 144(8):1983-1995. PubMed ID: 30230537
[TBL] [Abstract][Full Text] [Related]
18. Pituitary atypical teratoid rhabdoid tumor in a patient with prolactinoma: A unique description.
Barresi V; Lionti S; Raso A; Esposito F; Cannavò S; Angileri FF
Neuropathology; 2018 Jun; 38(3):260-267. PubMed ID: 29110337
[TBL] [Abstract][Full Text] [Related]
19. Atypical teratoid rhabdoid tumor in a child with neurofibromatosis type 2: A novel dual diagnosis.
Kotch C; Fisher MJ; Lin F; Zhong Y; Gallo D; Fan Z; Chen J; Santi M; Li MM
Cancer Genet; 2022 Apr; 262-263():1-4. PubMed ID: 34972035
[TBL] [Abstract][Full Text] [Related]
20. Ewing Sarcoma and Atypical Teratoid Rhabdoid Tumor: A FISH and Immunohistochemical Comparison.
Pacheco MC; Dolan M; Bendel A
Pediatr Dev Pathol; 2017; 20(5):381-386. PubMed ID: 28382842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
